EVŌQ Nano’s Post

This week, we’re releasing episode #7 of MedTech Unboxed, with Shaun Rothwell, CEO of EVŌQ Nano. In this episode, Shaun discusses how their EVQ-218 silver nanoparticle antimicrobial platform has the potential to significantly combat healthcare-associated infections (HAIs) and reduce thrombosis. HAIs impact over 1 million hospital patients annually, resulting in significant morbidity, mortality, and approximately $10 billion in healthcare costs each year. According to Shaun, over 20,000 people die every year from urinary catheter infections in the US alone. Our discussion includes: ➡️ Overview of the EVQ-218 silver nanoparticle technology (non-ionic) and why it is superior to conventional silver ions in inhibiting bacterial growth. ➡️ Efforts to reduce HAIs in indwelling catheters by preventing bacteria colonization and biofilm formation on catheter surfaces. ➡️ How EVQ-218 nanoparticles enhance antithrombotic properties in coatings to minimize the risk of blood coagulation. ➡️ Using high energy lasers to manufacture spherical nanoparticles at scale with high consistency in their new 60,000 square foot facility in Salt Lake City. Listen to the full episode here: https://lnkd.in/ehS5_aiQ #MedTechUnboxed #antimicrobialresistance #antimicrobial #AMR #HAIs

HYPERPLASTIC TISSUE RESPONSE FOLLOWING CONNECTIVE TISSUE GRAFTING While connective tissue graft shrinkage is a well-documented post-transplantation reaction, there is a literature gap concerning hyperplastic tissue response. This phenomenon is unaesthetic, may cause food retention and impaired lip  dynamic, and often causes anxiety, as patients perceive it as a malignant tumor.  It does not regress spontaneously. Previously published attempts to remove this unaesthetic tissue failed, sometimes triggering even more growth. We, Howie Gluckman and myself, just published in JERD a promising and viable treatment modality to effectively manage uncontrolled gingival overgrowth after connective tissue grafting. #JERD #AdriaDentalGroup #PolicliniciRident #HowardGluckman

The Pathway to Support Achievement of Definitive Closure: Technologies to Protect Surgical Wounds - June 5 at 2pm ET In this upcoming webinar, you'll join Dr. Hector Campbell, Dr. Mark Granick, and Dr. Vipul Dev as they discuss surgical techniques and the use of an antimicrobial skin substitute to achieve definitive closure through real world case examples. Register now: https://okt.to/HbYx3G Sponsored by Organogenesis

Enhancing wound healing through innovative technologies: microneedle patches and iontophoresis Frontiers https://lnkd.in/gVEEynxe

Biologics PRP + ESWT combination DataBiologics for shoulders and knees continues as predicted to improve performance and long term outcomes in shoulders and knees Delighted that Storz Medical STORZ MEDICAL AG is a Gold Sponsor BRITISH ASSOCIATION OF SPORT AND EXERCISE MEDICINE Conference Coventry 🗓️ 07 Nov, 4:15 PM 💉 Session: Injectables in Elite Sport: Evidence Base and Experience 🎤 Speaker: Dr Justin Lee In this session, Dr. Justin Lee will explore the growing role of injectables in sports medicine. He’ll address key questions like which injectables are best for specific injuries and what evidence supports their use. Essential for anyone focused on rapid recovery and injury management in elite sports. 🔗 Learn More - https://www.rfr.bz/lmi4ibw 🎟️ Get Tickets - https://www.rfr.bz/lmi4ibx #BASEM2024 #SportsMedicine #EliteAthletes #InjuryRecovery #Injectables #RapidRecovery

Last October, Dr. Thomas Serena showcased the effectiveness of DEBRICHEM® in removing biofilm during his booth talk at the 6th Global Wound Conference in Malaysia. Using the MolecuLight Fluorescent Imaging device, he demonstrated that DEBRICHEM® can debride wounds in just 60 seconds, outperforming traditional methods like scalpels and antiseptics. As evidenced by imaging, DEBRICHEM® not only quickly removes bacteria from the wound bed but also prevents reformation of biofilm over time at follow-up visit. Unlike conventional methods that fail to remove the entire biofilm at once, research has shown that DEBRICHEM® removes up to 99,99% of bacteria in a single application, allowing the body's immune response to prevent biofilm regrowth. Dr. Serena shared successful case studies, including a toe amputation and venous ulcer, highlighting the product's ability to improve healing times and patient outcomes. He emphasized DEBRICHEM®'s superiority in preparing wounds for advanced therapies, making it an essential tool for every clinician in wound care. 🎥 Watch the Talk: DEBRICHEM®'s Effect Assessed with MolecuLight Fluorescent Imaging 🎥 Quicken your debridement procedures and save valuable time and costs. Request a Demonstration: https://lnkd.in/edCNu2xb #WoundCare #Debridement #DEBRICHEM® #ChronicWounds #Biofilm #WoundHealing #InnovationInHealthcare #MedicalDevice

In this study, the hemocompatibility of different commercially available coated flow diverters was investigated using an in vitro blood circulation model (Chandler Loop System). The results for the activation of the coagulation cascade, the activation of platelets, the activation of leukocytes and the number of platelets are comparable for all coated devices and comparable to the control tube. This shows that the high antithrombogenic properties of the #HEAL coating are in line with other commercially available coatings. In addition to this, the activation of the complement system highlighted in the results of this study suggests a lower inflammatory reaction which could lead to decreased levels of hyperplasia with the HEAL Technology compared to other coatings. Acandis is very proud to offer the next generation of antithrombogenic coating in combination with great stent designs! Read the paper here: https://lnkd.in/gH6A2NfU

One of the greatest leaps forward in a technology I have seen to date! This technology is unbelievable. AI intelligence mapping / planning with fully automated robotic precision and resection!!

Clinical dilemmas in ovarian tissue cryopreservation https://lnkd.in/dkxZMjfd #ovariantissue #cryopreservation

☑️ Toku Eyes has received breakthrough designation from the FDA for its eye scan device that detects signs of chronic kidney disease by scanning the retinas, aiming to catch the disease early. ☑️ @Veris has partnered with Ohio University for a digital health pilot using the Veris Cancer Care platform, a remote data collection tool designed to detect complications early and reduce hospital visits. ☑️ GT Medical and Theragenics Corporation have partnered to expand access to radioactive Cesium-131 seeds implanted directly into or adjacent to tumors to deliver targeted radiation to cancer cells. ☑️ South Korea’s Medit has launched the i900 intraoral scanner worldwide, featuring advanced ergonomics and a third-generation Optical Engine. ☑️ Single Pass’ Kronos biopsy closure device secures FDA clearance. Mermaid Medical Group, Single Pass's US distribution partner, is set to commence Kronos biopsy closure device sales. #InsightswithSmarteeva #Medtech #complaintmanagement #Pharma #Smarteeva #biotech #medtechtrends #medtechindustry #medicaltechnology #technology #health #medicaldevicediagnostics #ai #mdr #recalls #complaints #mir #fda #cvr